- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01093144
Assessment of Pelvis Diameters as a Predictor for the Mode of Delivery ,Using Non-invasive, Ultrasound Based Measurements
March 24, 2010 updated by: Trig Medical Inc
Assessment of Pelvis Diameters as a Predictor for the Mode of Delivery ,Using Non-invasive, Ultrasound Based Measurements.
Assessing the relation between the Pelvis diameters measured by the LaborPro, and the mode of delivery(normal vaginal delivery/instrumental delivery/Caesarean section.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Assessing the relation between the Pelvis diameters measured by the LaborPro, and the mode of delivery(normal vaginal delivery/instrumental delivery/Caesarean section.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Aviv, Israel
- Shiba Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- A subject is eligible to participate in the study if she meets all of the following inclusion criteria:
Singleton pregnancy
- Pregnant adult woman in labor
- Willing to participate in the study and understands the study procedures
Exclusion Criteria:
- A subject is not eligible for participation in this study if he/she meets any of the following exclusion criteria scheduled for c/s active infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pelvis measurements influence on the Delivery mode
Time Frame: labor and delivery process
|
pregnant woman's during a routine visit in the ultrasound unit will be requested to sign a concent and will undergo pelvic measurement using the LaborPro system. statistic analysis will ensue in order to ascertain the relationship between pelvic measurement and the mode of delivery. |
labor and delivery process
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the influence of maternal parameters on delivery mode.
Time Frame: 1 year
|
Assessing the influence of relevant obstetric and maternal parameters on delivery mode in relation to the study measured parameters
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yinon Gilboa, Dr, Tel Hashomer Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Anticipated)
April 1, 2010
Study Completion (Anticipated)
April 1, 2010
Study Registration Dates
First Submitted
March 24, 2010
First Submitted That Met QC Criteria
March 24, 2010
First Posted (Estimate)
March 25, 2010
Study Record Updates
Last Update Posted (Estimate)
March 25, 2010
Last Update Submitted That Met QC Criteria
March 24, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CLP 006/2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
Clinical Trials on pelvic measurements using the LaborPro Device
-
Ankara City Hospital BilkentCompleted
-
Sanliurfa Mehmet Akif Inan Education and Research...CompletedDepressive Disorder | Restless Legs Syndrome | Anemia of Chronic Kidney Disease | Hemodialysis-Associated Pruritus | Malnutrition-Inflammation-Cachexia SyndromeTurkey
-
University Hospital, Strasbourg, FranceNot yet recruitingLewy Bodies DiseaseFrance
-
phenox Inc.CompletedIschemia | Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Stroke, Ischemic | Stroke, AcuteUnited States, Germany
-
Kessler FoundationRecruitingSCI - Spinal Cord InjuryUnited States
-
Kessler FoundationRecruiting
-
Central Hospital, Nancy, FranceUniversity of Lorraine; Centre National de la Recherche Scientifique, FranceNot yet recruitingClinical Evaluation of an Innovative Non-contact Optical Device for Skin Oxygenation Imaging (IMOXY)Obliterating Arteriopathy of the Lower Limbs | Chronic WoundsFrance
-
Lund University HospitalRecruitingLung Cancer | Lung Adenocarcinoma | Non-small Cell Lung Cancer | Squamous Cell Lung CancerSweden
-
Heidelberg UniversityKlaus Tschira Stiftung gGmbHCompleted
-
NeuroVasc TechnologiesTerminatedAcute Ischemic StrokeUnited States